🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the saftey of giving fluticasone furoate 200mcg/GW64...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-11-18
Trial ID
NCT01266980
Treatments Being Tested
The purpose of the study was to evaluate the effect of arginine/lysine solu...
Status
Completed
Location
Istituto Europeo di Oncologia
Start Date
2021-01-25
Trial ID
NCT04524442
Treatments Being Tested
The aim of this study is to evaluate difference in the rate of recovery of ...
Status
Completed
Location
Seoul National University Hospital
Start Date
2020-01-01
Trial ID
NCT04184401
The goal of this clinical trial is to evaluate the safety and effectiveness...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2025-01-07
Trial ID
NCT06737380
Treatments Being Tested
This study will test the hypothesis that the administration of a xanthine o...
Status
Completed
Location
University of Florida
Start Date
2005-08
Trial ID
NCT00241839
Treatments Being Tested
Inflammatory bowel disease (IBD), comprising crohn's disease (CD) and ulcer...
Status
Unknown
Location
Mohammed Ragab Osman
Start Date
2018-04
Trial ID
NCT03496246
In relation to their severity, hepatic diseases can significantly modify dr...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-18
Trial ID
NCT01266941
Treatments Being Tested
This is a descriptive, retrospective study involving patients from private ...
Status
Recruiting
Location
Research Site
Start Date
2026-03-31
Trial ID
NCT07370194
Stroke remains the fourth leading cause of death in the United States (seco...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT01954290
Treatments Being Tested
Secondary Data Collection Study; Safety And Effectiveness Of Selara Under J...
Status
Completed
Location
Pfizer Local Country Office
Start Date
2017-07-05
Trial ID
NCT03342690
Treatments Being Tested